Table 2 Biochemical parameters and findings
From: Multidisciplinary assessment of tako tsubo cardiomyopathy: a prospective case study
Variable | Initial findings | 48 hours | 3 months | P |
|---|---|---|---|---|
Troponin I (mg/L) | 2.70 (0.45-2.90) | 0.42 (0.17-0.76) | Not measured | < 0.001 |
Creatine kinase μkat/L | 2.55 (1.58-3.15) | 1.50 (1.00-1.90) | Not measured | 0.03 |
Creatin kinase MB (μg/L) | 11.60 (5.35-22.33) | 4.40 (2.80-5.10) | Not measured | 0.002 |
NT pro-brain natriuretic peptide (ng/L) | 389 (228-447) | 313 (275-702) | Not measured | 0.32 |
High-sensitivity C-reactive protein (mg/L) | 4.10 (2.90-6.70) | 10.50 (7.10-19.60) | Not measured | 0.02 |
Thyroid-stimulating hormone (mIU/L) | 1.20 (0.68-1.70) | Not measured | 1.10 (0.90-1.50) | 0.97 |
Thyroxine (pmol/L) | 14.30 (13.60-15.50) | Not measured | 14.00 (13.30-15.00) | 0.57 |
Cholesterol (mmol/L) | 6.10 (5.30-6.60) | Not measured | 5.40 (4.40-6.00) | 0.57 |
Low-density lipoprotein cholesterol (mmol/L) | 3.60 (2.70-4.40) | Not measured | 3.00 (2.10-3.50) | 0.52 |
High-density lipoprotein cholesterol (mmol/L) | 1.50 (1.20-1.50) | Not measured | 1.40 (1.30-1.60) | 0.18 |
Triglyceride (mmol/L) | 1.60 (1.20-2.20) | Not measured | 1.50 (1.20-2.40) | 0.41 |
Plasma adrenalin (nmol/l) * | 0.30 (0.30-0.40) | Not measured | 0.30 (0.30-0.30) | 1.00 |
Plasma noradrenalin (nmol/l) * | 3.70 (2.60-5.50) | Not measured | 3.30 (2.50-3.40) | 0.06 |